Without a clear single news headline driving it today, 10x Genomics (TXG) has drawn attention after recent share price moves, ...

The Transplant Company™ – a leading precision medicine company focused on the discovery, development, and commercialization ...

CareDx Inc. has entered a strategic collaboration with 10x Genomics to establish ImmuneScape, a multiomics research ...

Forbes contributors publish independent expert analyses and insights. Steven covers accessibility and assistive technologies. Aug 07, 2023, 01:54pm EDT Aug 07, 2023, 03:58pm EDT This article is more ...

What Happened? Shares of biotech company 10x Genomics (NASDAQ:TXG) jumped 2.5% in the afternoon session after several ...

10x Genomics reported 18% YoY revenue growth in Q4, reaching $184M, with instruments revenue seeing a remarkable surge of 71%. The company celebrated the successful launch of its cutting-edge platform ...

Detailed price information for 10X Genomics Inc (TXG-Q) from The Globe and Mail including charting and trades.

PLEASANTON — 10x Genomics has crafted plans for a major expansion of its Pleasanton operations through the purchase of a big property that it will develop as a modern campus, the biotech company said ...

10x Genomics (TXG) has been on my Compounding Healthcare “Bio Boom” speculative portfolio watch list since its IPO back in 2019. At that time, I was enthralled with their products, services, and R&D ...

10x Genomics (NASDAQ: TXG), a biotechnology company that designs and manufactures gene sequencing technology, was listed following its IPO in September. While the stock saw some volatility post its ...

10x Genomics, a developer of integrated solutions including instruments, consumables and software for analyzing biological systems at previously inaccessible resolution and scale, has disclosed plans ...

Detailed price information for 10X Genomics Inc (TXG-Q) from The Globe and Mail including charting and trades.